Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation?

Journal of Investigative Dermatology

Volumn 126, Issue 8, 2006, Pages 1693-1696

  Thomas, Nancy E ^a,b   Berwick, Marianne ^c   Cordeiro Stone, Marila ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYCLOBUTANE DERIVATIVE; CYCLOSPORIN; DNA POLYMERASE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PSORALEN; PYRIMIDINE;

CANCER RISK; CODON; DIMERIZATION; DNA DAMAGE; DNA REPLICATION; GENE MUTATION; GENOTOXICITY; HUMAN; MELANOCYTE; MELANOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION MUTAGENESIS; REVIEW; SUNBURN; SUNLIGHT; TANDEM REPEAT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

EID: 33746105691     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700458     Document Type: Note

References (32)

1. Besaratinia A, Pfeifer GP (2005) Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis. Carcinogenesis advance online publication December 12 2005, doi:10.1093/carcin/bgi311
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54
3. De Fabo EC, Noonan FP, Fears T, Merlino G (2004) Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 64:6372-6
4. Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P et al. (2004) Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet 41:270-2
5. Esposito F, Brankamp RG, Sinden RR (1988) DNA sequence specificity of 4,5′,8-trimethylpsoralen cross-linking. Effect of neighboring bases on cross-linking the 5-TA dinucleotide. J Biol Chem 263:11466-72
6. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P et al. (2005a) Meta-analysis of risk factors for cutaneous melanoma. I. Common and atypical naevi. Eur J Cancer 41:28-44
7. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P et al. (2005b) Metaanalysis of risk factors for cutaneous melanoma. II. Sun exposure. Eur J Cancer 41:45-60
8. Gibbs PE, McGregor WG, Maher VM, Nisson P, Lawrence CW (1998) A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta. Proc Natl Acad Sci USA 95:6876-80
9. Johnson RE, Washington MT, Prakash S, Prakash L (2000) Fidelity of human DNA polymerase eta. J Biol Chem 275:7447-50
10. Kreimer-Erlacher H, Seidl H, Back B, Cerroni L, Kerl H, Wolf P (2003) High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients. J Invest Dermatol 120:676-82
11. Kumar R, Angelini S, Snellman E, Hemminki K (2004) BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122:342-8
12. Lassacher A, Worda M, Kaddu S, Heitzer E, Legat F, Massone C et al. (2006) T1799A BRAF mutation is common in PUVA lentigines. J Invest Dermatol 126:1915-8
13. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T et al. (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95:1878-90
14. Masutani C, Kusumoto R, Iwai S, Hanaoka F (2000) Mechanisms of accurate translesion synthesis by human DNA polymerase eta. EMBO J 19:3100-9
15. McCulloch SD, Kokoska RJ, Chilkova O, Welch CM, Johansson E, Burgers PM et al. (2004a) Enzymatic switching for efficient and accurate translesion DNA replication. Nucleic Acids Res 32:4665-75
16. McCulloch SD, Kokoska RJ, Masutani C, Iwai S, Hanaoka F, Kunkel TA (2004b) Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity. Nature 428:97-100
17. Meyskens FL Jr., Farmer PJ, Anton-Culver H (2004) Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res 10:2581-3
18. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720-4
19. Pfeifer GP, You YH, Besaratinia A (2005) Mutations induced by ultraviolet light. Mutat Res 571:19-31
20. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19-20
21. Prakash S, Prakash L (2002) Translesion DNA synthesis in eukaryotes: a one- or two-polymerase affair. Genes Dev 16:1872-83
22. Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA et al. (2004) Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89:5175-80
23. Samokhvalov A, Hong L, Liu Y, Garguilo J, Nemanich RJ, Edwards GS et al. (2005) Oxidation potentials of human eumelanosomes and pheomelanosomes. Photochem Photobiol 81:145-8
24. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA et al. (2005) Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 65:6063-9
25. Seidl H, Kreimer-Erlacher H, Back B, Soyer HP, Hofler G, Kerl H et al. (2001) Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J Invest Dermatol 117:365-70
26. Sieben NL, Macropoulos P, Roemen GM, Kolkman-Uljee SM, Jan Fleuren G, Houmadi R et al. (2004) In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. J Pathol 202:336-40
27. Stern RS (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44:755-61
28. Tannapfel A, Sommerer F, Benicke M, Katalinic A, Uhlmann D, Witzigmann H et al. (2003) Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut 52:706-12
29. Thomas NE, Alexander A, Edmiston SN, Parrish E, Millikan RC, Berwick M et al. (2004) Tandem BRAF mutations in primary invasive melanomas. J Invest Dermatol 122:1245-50
30. Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW et al. (2001) Ultraviolet A and melanoma: a review. J Am Acad Dermatol 44:837-46
31. Wolf P, Kreimer-Erlacher H, Seidl H, Back B, Soyer HP, Kerl H (2004) The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients. J Invest Dermatol 122:190-200
32. Yazdi AS, Palmedo G, Flaig MJ, Puchta U, Reckwerth A, Rutten A et al. (2003) Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 121:1160-2